Healthco Healthcare and Wellness Reit
ASX:HCW
Healthco Healthcare and Wellness Reit
HealthCo Healthcare & Wellness REIT operates as a real estate investment trust. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-09-06. The firm is engaged in activities of investing in hospitals, aged care, childcare, government, life sciences & research, and primary care & wellness property assets, as well as other healthcare and wellness properties. HealthCo Healthcare & Wellness REIT is externally managed by a whole owned subsidiary of Home Consortium, manager of real assets. The firm has approximately 27 properties under its belt. Its portfolio is positioned on the eastern shore, with Queensland accounting for half of the properties.
HealthCo Healthcare & Wellness REIT operates as a real estate investment trust. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-09-06. The firm is engaged in activities of investing in hospitals, aged care, childcare, government, life sciences & research, and primary care & wellness property assets, as well as other healthcare and wellness properties. HealthCo Healthcare & Wellness REIT is externally managed by a whole owned subsidiary of Home Consortium, manager of real assets. The firm has approximately 27 properties under its belt. Its portfolio is positioned on the eastern shore, with Queensland accounting for half of the properties.
Portfolio Resilience: HealthCo reported strong operational metrics with 100% rent collection, 99% occupancy, and 4.2% NOI growth in the half.
Healthscope Situation: The Healthscope issue remains unresolved, but rent is current through February 2026 and alternative tenant agreements are ready for all 11 hospitals.
Valuation Impact: New alternative tenant deals would result in a 10–15% near-term reduction in asset valuations if executed, assuming cap rates hold steady.
Distributions Paused: Both listed and unlisted funds have paused distributions to preserve balance sheet flexibility until the Healthscope matter is resolved.
Balance Sheet Strength: Gearing reduced to 28.5%, below target, and $155 million in cash and undrawn debt was held at period end.
No FY26 Guidance: Management is not providing FY26 guidance or resuming distributions until the Healthscope situation is clarified.
